| Year |
Citation |
Score |
| 2024 |
Contreras KM, Buzzi B, Vaughn J, Caillaud M, Altarifi AA, Olszewski E, Walentiny DM, Beardsley PM, Damaj MI. Characterization and validation of a spontaneous acute and protracted oxycodone withdrawal model in male and female mice. Pharmacology, Biochemistry, and Behavior. 173795. PMID 38834159 DOI: 10.1016/j.pbb.2024.173795 |
0.367 |
|
| 2024 |
Elder HJ, Walentiny DM, Beardsley PM. Enantiomeric contributions to methamphetamine's bidirectional effects on basal and fentanyl-depressed respiration in mice. Pharmacology, Biochemistry, and Behavior. 238: 173735. PMID 38373600 DOI: 10.1016/j.pbb.2024.173735 |
0.799 |
|
| 2023 |
Elder HJ, Walentiny DM, Beardsley PM. Theophylline reverses oxycodone's but not fentanyl's respiratory depression in mice while caffeine is ineffective against both opioids. Pharmacology, Biochemistry, and Behavior. 229: 173601. PMID 37414364 DOI: 10.1016/j.pbb.2023.173601 |
0.801 |
|
| 2023 |
Varshneya NB, Hassanien SH, Holt MC, Stevens DL, Layle NK, Bassman JR, Iula DM, Beardsley PM. Fentanyl analog structure-activity relationships demonstrate determinants of diverging potencies for antinociception and respiratory depression. Pharmacology, Biochemistry, and Behavior. 226: 173572. PMID 37236405 DOI: 10.1016/j.pbb.2023.173572 |
0.812 |
|
| 2022 |
Elder HJ, Varshneya NB, Walentiny DM, Beardsley PM. Amphetamines modulate fentanyl-depressed respiration in a bidirectional manner. Drug and Alcohol Dependence. 243: 109740. PMID 36608481 DOI: 10.1016/j.drugalcdep.2022.109740 |
0.764 |
|
| 2022 |
Varshneya NB, Walentiny DM, Stevens DL, Walker TD, Akinfiresoye LR, Beardsley PM. Structurally diverse fentanyl analogs yield differential locomotor activities in mice. Pharmacology, Biochemistry, and Behavior. 173496. PMID 36435268 DOI: 10.1016/j.pbb.2022.173496 |
0.786 |
|
| 2022 |
Varshneya NB, Hassanien SH, Holt MC, Stevens DL, Layle NK, Bassman JR, Iula DM, Beardsley PM. Respiratory depressant effects of fentanyl analogs are opioid receptor-mediated. Biochemical Pharmacology. 195: 114805. PMID 34673011 DOI: 10.1016/j.bcp.2021.114805 |
0.813 |
|
| 2021 |
Varshneya NB, Walentiny DM, Moisa LT, Walker TD, Akinfiresoye LR, Beardsley PM. Fentanyl-related substances elicit antinociception and hyperlocomotion in mice via opioid receptors. Pharmacology, Biochemistry, and Behavior. 173242. PMID 34302853 DOI: 10.1016/j.pbb.2021.173242 |
0.812 |
|
| 2021 |
Carper M, Contreras KM, Walentiny DM, Beardsley PM, Damaj MI. Validation and characterization of oxycodone physical dependence in C57BL/6J mice. European Journal of Pharmacology. 174111. PMID 33901461 DOI: 10.1016/j.ejphar.2021.174111 |
0.381 |
|
| 2020 |
Walentiny DM, Komla E, Moisa LT, Mustafa MA, Poklis JL, Akbarali HI, Beardsley PM. Methylnaltrexone crosses the blood-brain barrier and attenuates centrally-mediated behavioral effects of morphine and oxycodone in mice. Neuropharmacology. 108437. PMID 33316279 DOI: 10.1016/j.neuropharm.2020.108437 |
0.348 |
|
| 2019 |
Zheng Y, Obeng S, Reinecke BA, Chen C, Phansalkar PS, Walentiny DM, Gerk PM, Liu-Chen LY, Selley DE, Beardsley PM, Zhang Y. Pharmacological characterization of 17-cyclopropylmethyl-3,14-dihydroxy-4,5-epoxy-6-[(3'-fluoro-4'-pyridyl)acetamido]morphinan (NFP) as a dual selective MOR/KOR ligand with potential applications in treating opioid use disorder. European Journal of Pharmacology. 172812. PMID 31743739 DOI: 10.1016/J.Ejphar.2019.172812 |
0.786 |
|
| 2019 |
Varshneya NB, Walentiny DM, Moisa LT, Walker TD, Akinfiresoye LR, Beardsley PM. Opioid-like antinociceptive and locomotor effects of emerging fentanyl-related substances. Neuropharmacology. PMID 30904478 DOI: 10.1016/J.Neuropharm.2019.03.023 |
0.784 |
|
| 2019 |
Walentiny DM, Moisa LT, Beardsley PM. Oxycodone-Like Discriminative Stimulus Effects of Fentanyl-Related Emerging Drugs of Abuse in Mice. Neuropharmacology. PMID 30735691 DOI: 10.1016/J.Neuropharm.2019.02.007 |
0.789 |
|
| 2018 |
Walentiny DM, Wiebelhaus JM, Beardsley PM. Nociceptin/orphanin FQ receptors modulate the discriminative stimulus effects of oxycodone in C57BL/6 mice. Drug and Alcohol Dependence. 187: 335-342. PMID 29705547 DOI: 10.1016/J.Drugalcdep.2018.02.035 |
0.787 |
|
| 2017 |
Bachtell RK, Jones JD, Heinzerling KG, Beardsley PM, Comer SD. Glial and neuroinflammatory targets for treating substance use disorders. Drug and Alcohol Dependence. 180: 156-170. PMID 28892721 DOI: 10.1016/J.Drugalcdep.2017.08.003 |
0.302 |
|
| 2017 |
Owens RA, Mustafa MA, Ignatowska-Jankowska BM, Damaj MI, Beardsley PM, Wiley JL, Niphakis MJ, Cravatt BF, Lichtman AH. Inhibition of the endocannabinoid-regulating enzyme monoacylglycerol lipase elicits a CB1 receptor-mediated discriminative stimulus in mice. Neuropharmacology. PMID 28673548 DOI: 10.1016/J.Neuropharm.2017.06.032 |
0.534 |
|
| 2017 |
Enga RM, Rice AC, Weller P, Subler MA, Lee D, Hall CP, Windle JJ, Beardsley PM, van den Oord EJ, McClay JL. Initial characterization of behavior and ketamine response in a mouse knockout of the post-synaptic effector gene Anks1b. Neuroscience Letters. PMID 28115237 DOI: 10.1016/J.Neulet.2017.01.044 |
0.343 |
|
| 2016 |
Enga RM, Jackson A, Damaj MI, Beardsley PM. Oxycodone physical dependence and its oral self-administration in C57BL/6J mice. European Journal of Pharmacology. PMID 27393461 DOI: 10.1016/J.Ejphar.2016.07.006 |
0.436 |
|
| 2016 |
Poland RS, Hahn Y, Knapp PE, Beardsley PM, Bowers MS. Ibudilast attenuates expression of behavioral sensitization to cocaine in male and female rats. Neuropharmacology. PMID 27343385 DOI: 10.1016/J.Neuropharm.2016.06.024 |
0.374 |
|
| 2016 |
Owens RA, Ignatowska-Jankowska BM, Mustafa M, Beardsley PM, Wiley JL, Jali A, Selley DE, Niphakis M, Cravatt BF, Lichtman AH. Discriminative Stimulus Properties of the Endocannabinoid Catabolic Enzyme Inhibitor SA-57 in Mice. The Journal of Pharmacology and Experimental Therapeutics. PMID 27307500 DOI: 10.1124/Jpet.115.229492 |
0.595 |
|
| 2015 |
Wiebelhaus JM, Walentiny DM, Beardsley PM. Effects of acute and repeated administration of oxycodone and naloxone-precipitated withdrawal on Intracranial Self-Stimulation (ICSS) in rats. The Journal of Pharmacology and Experimental Therapeutics. PMID 26491062 DOI: 10.1124/Jpet.115.228940 |
0.794 |
|
| 2015 |
Vengeliene V, Moeller A, Meinhardt MW, Beardsley PM, Sommer WH, Spanagel R, Bespalov A. The Calpain Inhibitor A-705253 Attenuates Alcohol-Seeking and Relapse with Low Side-Effect Profile. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 26216521 DOI: 10.1038/Npp.2015.225 |
0.31 |
|
| 2015 |
McClay JL, Vunck SA, Batman AM, Crowley JJ, Vann RE, Beardsley PM, van den Oord EJ. Neurochemical Metabolomics Reveals Disruption to Sphingolipid Metabolism Following Chronic Haloperidol Administration. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. PMID 25850894 DOI: 10.1007/S11481-015-9605-1 |
0.769 |
|
| 2015 |
Vengeliene V, Moeller A, Meinhardt MW, Beardsley P, Sommer WH, Spanagel R, Bespalov A. Sy09-2The Calpain Inhibitor A-705253 Attenuates Alcohol-Seeking And Relapse With Low Side-Effect Profile Alcohol and Alcoholism. 50. DOI: 10.1093/Alcalc/Agv076.35 |
0.301 |
|
| 2014 |
Wiley JL, Walentiny DM, Wright MJ, Beardsley PM, Burston JJ, Poklis JL, Lichtman AH, Vann RE. Endocannabinoid contribution to Δ9-tetrahydrocannabinol discrimination in rodents. European Journal of Pharmacology. 737: 97-105. PMID 24858366 DOI: 10.1016/J.Ejphar.2014.05.013 |
0.778 |
|
| 2014 |
El-Hage N, Rodriguez M, Podhaizer EM, Zou S, Dever SM, Snider SE, Knapp PE, Beardsley PM, Hauser KF. Ibudilast (AV411), and its AV1013 analog, reduce HIV-1 replication and neuronal death induced by HIV-1 and morphine. Aids (London, England). 28: 1409-19. PMID 24732776 DOI: 10.1097/Qad.0000000000000291 |
0.69 |
|
| 2014 |
Beardsley PM, Hauser KF. Glial modulators as potential treatments of psychostimulant abuse. Advances in Pharmacology (San Diego, Calif.). 69: 1-69. PMID 24484974 DOI: 10.1016/B978-0-12-420118-7.00001-9 |
0.318 |
|
| 2013 |
Adkins DE, McClay JL, Vunck SA, Batman AM, Vann RE, Clark SL, Souza RP, Crowley JJ, Sullivan PF, van den Oord EJ, Beardsley PM. Behavioral metabolomics analysis identifies novel neurochemical signatures in methamphetamine sensitization. Genes, Brain, and Behavior. 12: 780-91. PMID 24034544 DOI: 10.1111/Gbb.12081 |
0.75 |
|
| 2013 |
Aberg KA, Xie LY, McClay JL, Nerella S, Vunck S, Snider S, Beardsley PM, van den Oord EJ. Testing two models describing how methylome-wide studies in blood are informative for psychiatric conditions. Epigenomics. 5: 367-77. PMID 23895651 DOI: 10.2217/Epi.13.36 |
0.73 |
|
| 2013 |
McClay JL, Adkins DE, Vunck SA, Batman AM, Vann RE, Clark SL, Beardsley PM, van den Oord EJ. Large-scale neurochemical metabolomics analysis identifies multiple compounds associated with methamphetamine exposure. Metabolomics : Official Journal of the Metabolomic Society. 9: 392-402. PMID 23554582 DOI: 10.1007/S11306-012-0456-Y |
0.766 |
|
| 2013 |
Snider SE, Hendrick ES, Beardsley PM. Glial cell modulators attenuate methamphetamine self-administration in the rat. European Journal of Pharmacology. 701: 124-30. PMID 23375937 DOI: 10.1016/J.Ejphar.2013.01.016 |
0.756 |
|
| 2013 |
Shelton KL, Hendrick ES, Beardsley PM. Efficacy of buspirone for attenuating cocaine and methamphetamine reinstatement in rats. Drug and Alcohol Dependence. 129: 210-6. PMID 23374566 DOI: 10.1016/J.Drugalcdep.2013.01.003 |
0.317 |
|
| 2013 |
Webster K, Hillhouse T, Donahue T, Friar M, Joseph B, Beardsley P, Windle J, Stewart J, Porter J. A.10 - EFFECTS OF D-AMPHETAMINE IN VESICULAR MONOAMINE TRANSPORTER (VMAT)1 KNOCKOUT MICE SUGGEST A SCHIZOPHRENIC PHENOTYPE IN CONDITIONED AND UNCONDITIONED BEHAVIOR Behavioural Pharmacology. 24: e25. DOI: 10.1097/01.Fbp.0000434771.21238.50 |
0.57 |
|
| 2012 |
Beardsley PM, Shelton KL. Prime-, stress-, and cue-induced reinstatement of extinguished drug-reinforced responding in rats: cocaine as the prototypical drug of abuse. Current Protocols in Neuroscience / Editorial Board, Jacqueline N. Crawley ... [Et Al.]. Unit 9.39. PMID 23093352 DOI: 10.1002/0471142301.Ns0939S61 |
0.353 |
|
| 2012 |
Snider SE, Vunck SA, van den Oord EJ, Adkins DE, McClay JL, Beardsley PM. The glial cell modulators, ibudilast and its amino analog, AV1013, attenuate methamphetamine locomotor activity and its sensitization in mice. European Journal of Pharmacology. 679: 75-80. PMID 22306241 DOI: 10.1016/J.Ejphar.2012.01.013 |
0.781 |
|
| 2011 |
McClay JL, Adkins DE, Aberg K, Bukszár J, Khachane AN, Keefe RS, Perkins DO, McEvoy JP, Stroup TS, Vann RE, Beardsley PM, Lieberman JA, Sullivan PF, van den Oord EJ. Genome-wide pharmacogenomic study of neurocognition as an indicator of antipsychotic treatment response in schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 36: 616-26. PMID 21107309 DOI: 10.1038/Npp.2010.193 |
0.634 |
|
| 2010 |
Batman AM, Dutta AK, Reith ME, Beardsley PM. The selective dopamine uptake inhibitor, D-84, suppresses cocaine self-administration, but does not occasion cocaine-like levels of generalization. European Journal of Pharmacology. 648: 127-32. PMID 20840845 DOI: 10.1016/J.Ejphar.2010.08.051 |
0.348 |
|
| 2010 |
Beardsley PM, Shelton KL, Hendrick E, Johnson KW. The glial cell modulator and phosphodiesterase inhibitor, AV411 (ibudilast), attenuates prime- and stress-induced methamphetamine relapse. European Journal of Pharmacology. 637: 102-8. PMID 20399770 DOI: 10.1016/J.Ejphar.2010.04.010 |
0.43 |
|
| 2010 |
Beardsley PM, Pollard GT, Howard JL, Carroll FI. Effectiveness of analogs of the kappa opioid receptor antagonist (3R)-7-hydroxy-N-((1S)-1-{[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl]methyl}-2-methylpropyl)-1,2,3,4-tetrahydro-3-isoquinolinecarboxamide (JDTic) to reduce U50,488-induced diuresis and stress-induced cocaine reinstatement in rats. Psychopharmacology. 210: 189-98. PMID 20372878 DOI: 10.1007/S00213-010-1846-3 |
0.456 |
|
| 2009 |
Kharkar PS, Batman AM, Zhen J, Beardsley PM, Reith ME, Dutta AK. Synthesis and biological characterization of (3R,4R)-4-(2-(benzhydryloxy)ethyl)-1-((R)-2-hydroxy-2-phenylethyl)-piperidin-3-ol and its stereoisomers for activity toward monoamine transporters. Chemmedchem. 4: 1075-85. PMID 19449323 DOI: 10.1002/Cmdc.200900085 |
0.328 |
|
| 2009 |
Beardsley PM, Thomas BF, McMahon LR. Cannabinoid CB1 receptor antagonists as potential pharmacotherapies for drug abuse disorders. International Review of Psychiatry (Abingdon, England). 21: 134-42. PMID 19367507 DOI: 10.1080/09540260902782786 |
0.368 |
|
| 2008 |
Shelton KL, Beardsley PM. Effect of drug-paired exteroceptive stimulus presentations on methamphetamine reinstatement in rats. Pharmacology, Biochemistry, and Behavior. 90: 434-40. PMID 18456312 DOI: 10.1016/J.Pbb.2008.03.028 |
0.352 |
|
| 2006 |
Newman JL, Beardsley PM. Effects of memantine, haloperidol, and cocaine on primary and conditioned reinforcement associated with cocaine in rhesus monkeys. Psychopharmacology. 185: 142-9. PMID 16425059 DOI: 10.1007/S00213-005-0282-2 |
0.605 |
|
| 2006 |
Vann RE, Balster RL, Beardsley PM. Dose, duration, and pattern of nicotine administration as determinants of behavioral dependence in rats. Psychopharmacology. 184: 482-93. PMID 16001123 DOI: 10.1007/S00213-005-0037-0 |
0.674 |
|
| 2005 |
Beardsley PM, Howard JL, Shelton KL, Carroll FI. Differential effects of the novel kappa opioid receptor antagonist, JDTic, on reinstatement of cocaine-seeking induced by footshock stressors vs cocaine primes and its antidepressant-like effects in rats. Psychopharmacology. 183: 118-26. PMID 16184376 DOI: 10.1007/S00213-005-0167-4 |
0.418 |
|
| 2005 |
Beardsley PM, Thomas BF. Current evidence supporting a role of cannabinoid CB1 receptor (CB1R) antagonists as potential pharmacotherapies for drug abuse disorders. Behavioural Pharmacology. 16: 275-96. PMID 16148435 DOI: 10.1097/00008877-200509000-00003 |
0.374 |
|
| 2005 |
Batman AM, Munzar P, Beardsley PM. Attenuation of nicotine's discriminative stimulus effects in rats and its locomotor activity effects in mice by serotonergic 5-HT2A/2C receptor agonists. Psychopharmacology. 179: 393-401. PMID 15565434 DOI: 10.1007/S00213-004-2035-Z |
0.396 |
|
| 2004 |
Kolhatkar R, Cook CD, Ghorai SK, Deschamps J, Beardsley PM, Reith ME, Dutta AK. Further structurally constrained analogues of cis-(6-benzhydrylpiperidin-3-yl)benzylamine with elucidation of bioactive conformation: discovery of 1,4-diazabicyclo[3.3.1]nonane derivatives and evaluation of their biological properties for the monoamine transporters. Journal of Medicinal Chemistry. 47: 5101-13. PMID 15456254 DOI: 10.1021/Jm049796T |
0.326 |
|
| 2004 |
Beardsley PM, Aceto MD, Cook CD, Bowman ER, Newman JL, Harris LS. Discriminative stimulus, reinforcing, physical dependence, and antinociceptive effects of oxycodone in mice, rats, and rhesus monkeys. Experimental and Clinical Psychopharmacology. 12: 163-72. PMID 15301633 DOI: 10.1037/1064-1297.12.3.163 |
0.65 |
|
| 2004 |
Cook CD, Beardsley PM. Modulation of the discriminative stimulus effects of mu opioid agonists in rats: II. Effects of dopamine D2/3 agonists. Behavioural Pharmacology. 15: 75-83. PMID 15075629 DOI: 10.1097/00008877-200402000-00009 |
0.341 |
|
| 2004 |
Cook CD, Beardsley PM. Modulation of the discriminative stimulus effects of mu opioid agonists in rats: I. Effects of dopamine D2/3 antagonists. Behavioural Pharmacology. 15: 65-74. PMID 15075628 DOI: 10.1097/00008877-200402000-00008 |
0.346 |
|
| 2004 |
Cook CD, Newman JL, Winfree JC, Beardsley PM. Modulation of the locomotor activating effects of the noncompetitive NMDA receptor antagonist MK801 by dopamine D2/3 receptor agonists in mice. Pharmacology, Biochemistry, and Behavior. 77: 309-18. PMID 14751459 DOI: 10.1016/J.Pbb.2003.11.002 |
0.633 |
|
| 2003 |
Cook CD, Beardsley PM. The modulatory actions of dopamine D2/3 agonists and antagonists on the locomotor-activating effects of morphine and caffeine in mice. Pharmacology, Biochemistry, and Behavior. 75: 363-71. PMID 12873628 DOI: 10.1016/S0091-3057(03)00090-X |
0.473 |
|
| 2003 |
Kozikowski AP, Johnson KM, Deschaux O, Bandyopadhyay BC, Araldi GL, Carmona G, Munzar P, Smith MP, Balster RL, Beardsley PM, Tella SR. Mixed cocaine agonist/antagonist properties of (+)-methyl 4beta-(4-chlorophenyl)-1-methylpiperidine-3alpha-carboxylate, a piperidine-based analog of cocaine. The Journal of Pharmacology and Experimental Therapeutics. 305: 143-50. PMID 12649362 DOI: 10.1124/Jpet.102.046318 |
0.329 |
|
| 2003 |
Ghorai SK, Cook C, Davis M, Venkataraman SK, George C, Beardsley PM, Reith ME, Dutta AK. High affinity hydroxypiperidine analogues of 4-(2-benzhydryloxyethyl)-1-(4-fluorobenzyl)piperidine for the dopamine transporter: stereospecific interactions in vitro and in vivo. Journal of Medicinal Chemistry. 46: 1220-8. PMID 12646032 DOI: 10.1021/Jm020275K |
0.335 |
|
| 2002 |
Beardsley PM, Ratti E, Balster RL, Willetts J, Trist D. The selective glycine antagonist gavestinel lacks phencyclidine-like behavioral effects. Behavioural Pharmacology. 13: 583-92. PMID 12409996 |
0.319 |
|
| 2002 |
Newman JL, Vann RE, May EL, Beardsley PM. Heroin discriminative stimulus effects of methadone, LAAM and other isomers of acetylmethadol in rats. Psychopharmacology. 164: 108-14. PMID 12373424 DOI: 10.1007/S00213-002-1198-8 |
0.738 |
|
| 2002 |
Cook CD, Carroll FI, Beardsley PM. RTI 113, a 3-phenyltropane analog, produces long-lasting cocaine-like discriminative stimulus effects in rats and squirrel monkeys. European Journal of Pharmacology. 442: 93-8. PMID 12020686 DOI: 10.1016/S0014-2999(02)01501-7 |
0.343 |
|
| 2002 |
Cook CD, Aceto MD, Coop A, Beardsley PM. Effects of the putative antagonist NCS382 on the behavioral pharmacological actions of gammahydroxybutyrate in mice. Psychopharmacology. 160: 99-106. PMID 11862379 DOI: 10.1007/S00213-001-0951-8 |
0.436 |
|
| 2002 |
Dutta AK, Davis MC, Fei XS, Beardsley PM, Cook CD, Reith ME. Expansion of structure-activity studies of piperidine analogues of 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazine (GBR 12935) compounds by altering substitutions in the N-benzyl moiety and behavioral pharmacology of selected molecules. Journal of Medicinal Chemistry. 45: 654-62. PMID 11806716 DOI: 10.1021/Jm010316X |
0.342 |
|
| 2001 |
Cook CD, Carroll IF, Beardsley PM. Cocaine-like discriminative stimulus effects of novel cocaine and 3-phenyltropane analogs in the rat. Psychopharmacology. 159: 58-63. PMID 11797070 DOI: 10.1007/S002130100891 |
0.313 |
|
| 2001 |
Willmore CB, Bespalov AY, Beardsley PM. Competitive and noncompetitive NMDA antagonist effects in rats trained to discriminate lever-press counts. Pharmacology, Biochemistry, and Behavior. 69: 493-502. PMID 11509209 DOI: 10.1016/S0091-3057(01)00568-8 |
0.373 |
|
| 2001 |
Bespalov AY, Zvartau EE, Beardsley PM. Opioid-NMDA receptor interactions may clarify conditioned (associative) components of opioid analgesic tolerance. Neuroscience and Biobehavioral Reviews. 25: 343-53. PMID 11445139 DOI: 10.1016/S0149-7634(01)00018-5 |
0.353 |
|
| 2001 |
Dutta AK, Fei XS, Beardsley PM, Newman JL, Reith ME. Structure-activity relationship studies of 4-[2-(diphenylmethoxy)ethyl]-1-benzylpiperidine derivatives and their N-analogues: evaluation of O-and N-analogues and their binding to monoamine transporters. Journal of Medicinal Chemistry. 44: 937-48. PMID 11300876 DOI: 10.1021/Jm000311K |
0.582 |
|
| 2000 |
Bespalov AY, Dravolina OA, Zvartau EE, Beardsley PM, Balster RL. Effects of NMDA receptor antagonists on cocaine-conditioned motor activity in rats. European Journal of Pharmacology. 390: 303-11. PMID 10708738 DOI: 10.1016/S0014-2999(99)00927-9 |
0.423 |
|
| 1999 |
Bespalov AY, Balster RL, Beardsley PM. N-Methyl-D-aspartate receptor antagonists and the development of tolerance to the discriminative stimulus effects of morphine in rats. The Journal of Pharmacology and Experimental Therapeutics. 290: 20-7. PMID 10381755 |
0.379 |
|
| 1999 |
Bespalov AY, Tokarz ME, Bowen SE, Balster RL, Beardsley PM. Effects of test conditions on the outcome of place conditioning with morphine and naltrexone in mice. Psychopharmacology. 141: 118-22. PMID 9952035 DOI: 10.1007/S002130050815 |
0.467 |
|
| 1998 |
Bespalov AY, Beardsley PM, Balster RL. Interactions between N-methyl-D-aspartate receptor antagonists and the discriminative stimulus effects of morphine in rats. Pharmacology, Biochemistry, and Behavior. 60: 507-17. PMID 9632234 DOI: 10.1016/S0091-3057(98)00006-9 |
0.381 |
|
| 1996 |
Beardsley PM, Balster RL, Harris LS. Evaluation of the discriminative stimulus and reinforcing effects of gammahydroxybutyrate (GHB). Psychopharmacology. 127: 315-22. PMID 8923566 DOI: 10.1007/s002130050092 |
0.305 |
|
| 1992 |
Chandrakumar NS, Stapelfeld A, Beardsley PM, Lopez OT, Drury B, Anthony E, Savage MA, Williamson LN, Reichman M. Analogs of the delta opioid receptor selective cyclic peptide [2-D-penicillamine,5-D-penicillamine]-enkephalin: 2',6'-dimethyltyrosine and Gly3-Phe4 amide bond isostere substitutions. Journal of Medicinal Chemistry. 35: 2928-38. PMID 1323677 |
0.398 |
|
| 1989 |
Knisely JS, Beardsley PM, Aceto MD, Balster RL, Harris LS. Assessment of the abuse potential of acetorphan, an enkephalinase inhibitor. Drug and Alcohol Dependence. 23: 143-51. PMID 2702924 DOI: 10.1016/0376-8716(89)90020-3 |
0.369 |
|
| 1987 |
Beardsley PM, Scimeca JA, Martin BR. Studies on the agonistic activity of delta 9-11-tetrahydrocannabinol in mice, dogs and rhesus monkeys and its interactions with delta 9-tetrahydrocannabinol. The Journal of Pharmacology and Experimental Therapeutics. 241: 521-6. PMID 3033218 |
0.32 |
|
| Show low-probability matches. |